Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02628002 · ClinicalTrials.gov registry record · NA
Anti-gravity Treadmill Exercise in Stress Myocardial Perfusion Imaging
A NA study, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT02628002: Completed NA study, sponsored by University of Cincinnati.
NCT02628002 is a NA study that has completed, run by University of Cincinnati. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02628002, a NA study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
This study will test the hypothesis that the anti-gravity treadmill can be safely used in stress nuclear myocardial perfusion imaging in patients unable to perform conventional treadmill exercise. This will be foundational evidence on which to consider a larger clinical trial to show that the anti-gravity treadmill improves diagnostic specificity across all cardiovascular stress testing modalities including treadmill-alone, exercise stress echocardiogram, exercise SPECT as well as having implications for cardiac PET and MRI in the future.
Primary Outcome
Patients who are unable to perform conventional treadmill exercise will be exercised to target heart rate on the anti-gravity treadmill for stress nuclear myocardial perfusion imaging.
Interventions
- DEVICE Antigravity treadmill (Alter-G)
- DEVICE Conventional treadmill/regadenoson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02628002 record still lists
NCT02628002 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Antigravity treadmill (Alter-G) is the first listed.
NCT02628002 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02628002 about?
NCT02628002 is a clinical study titled "Anti-gravity Treadmill Exercise in Stress Myocardial Perfusion Imaging". This study will test the hypothesis that the anti-gravity treadmill can be safely used in stress nuclear myocardial perfusion imaging in patients unable to perform conventional treadmill exercise. This will be foundational evidence on which to consider a larger clinical trial to show that the anti-...
What is the current status of trial NCT02628002?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2015-12. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02628002?
The interventions under investigation include: Antigravity treadmill (Alter-G) (DEVICE), Conventional treadmill/regadenoson (DEVICE).
Who is sponsoring clinical trial NCT02628002?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02628002's enrollment target sits among peer trials
49 1379th of 2000 higher than 620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia